NO152839C - ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES. - Google Patents
ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES.Info
- Publication number
- NO152839C NO152839C NO790521A NO790521A NO152839C NO 152839 C NO152839 C NO 152839C NO 790521 A NO790521 A NO 790521A NO 790521 A NO790521 A NO 790521A NO 152839 C NO152839 C NO 152839C
- Authority
- NO
- Norway
- Prior art keywords
- carbostyric
- derivatives
- preparation
- therapeutic active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19782806721 DE2806721A1 (en) | 1978-02-17 | 1978-02-17 | Substd. alkoxy-carbostyril derivs. - useful as antithrombotic and cardioactive agents, used for treating thromboembolic disorders and arteriosclerosis |
DE19782853314 DE2853314A1 (en) | 1978-12-09 | 1978-12-09 | Substd. alkoxy carbostyril, di:hydro-carbostyril and oxindole derivs. - with positive inotropic and antithrombotic activity |
Publications (3)
Publication Number | Publication Date |
---|---|
NO790521L NO790521L (en) | 1979-08-20 |
NO152839B NO152839B (en) | 1985-08-19 |
NO152839C true NO152839C (en) | 1985-11-27 |
Family
ID=25773852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO790521A NO152839C (en) | 1978-02-17 | 1979-02-16 | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES. |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0003771B1 (en) |
JP (1) | JPS54132581A (en) |
AT (1) | AT374183B (en) |
AU (1) | AU523147B2 (en) |
CA (1) | CA1116600A (en) |
CS (1) | CS227005B2 (en) |
DD (1) | DD141829A5 (en) |
DE (1) | DE2963868D1 (en) |
DK (1) | DK157017C (en) |
ES (3) | ES477517A1 (en) |
FI (1) | FI69064C (en) |
GR (1) | GR66565B (en) |
HK (1) | HK50485A (en) |
HU (1) | HU177522B (en) |
IE (1) | IE48179B1 (en) |
IL (1) | IL56677A (en) |
NO (1) | NO152839C (en) |
NZ (1) | NZ189685A (en) |
PH (1) | PH16698A (en) |
PL (3) | PL119177B1 (en) |
PT (1) | PT69244A (en) |
RO (2) | RO76683A (en) |
SU (2) | SU843739A3 (en) |
YU (1) | YU41146B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1171624B (en) * | 1980-11-12 | 1987-06-10 | Thomae Gmbh Dr K | INDOLINONES EQUIPPED WITH PHARMACEUTICAL PROPERTIES AND PROCEDURE FOR THEIR PRODUCTION |
US4442111A (en) * | 1981-07-25 | 1984-04-10 | Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung | Antithrombotic sulfimino and sulfoximino indolinones-2 |
DE3217012A1 (en) * | 1982-05-06 | 1983-11-10 | Dr. Karl Thomae Gmbh, 7950 Biberach | BENZOXAZIN-2-ONE, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
CA2093633A1 (en) * | 1991-08-23 | 1993-02-24 | Seiji Sato | Carbostyril derivative and platelets aggregation inhibitory agent |
JP2004529110A (en) | 2001-03-06 | 2004-09-24 | アストラゼネカ アクチボラグ | Indole derivatives with vascular damage activity |
MY129350A (en) | 2001-04-25 | 2007-03-30 | Bristol Myers Squibb Co | Aripiprazole oral solution |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5082218A (en) * | 1973-11-10 | 1975-07-03 | ||
US3904761A (en) * | 1974-01-25 | 1975-09-09 | Hoechst Co American | Method of preventing thrombosis |
FI59246C (en) * | 1974-06-24 | 1981-07-10 | Otsuka Pharma Co Ltd | FOERFARANDE FOER FRAMSTAELLNING AV BENSCYKLOAMIDDERIVAT ANVAENDBARA VID TROMBOS- OCH EMBOLITERAPIN |
JPS5321176A (en) * | 1976-08-09 | 1978-02-27 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivatives |
NZ187452A (en) * | 1977-06-10 | 1980-05-27 | Otsuka Pharma Co Ltd | N- substituted-aminocarbonylpropoxy-carbostyrils and their preparation |
-
1979
- 1979-01-31 SU SU792716799A patent/SU843739A3/en active
- 1979-02-07 EP EP79100348A patent/EP0003771B1/en not_active Expired
- 1979-02-07 ES ES477517A patent/ES477517A1/en not_active Expired
- 1979-02-07 DE DE7979100348T patent/DE2963868D1/en not_active Expired
- 1979-02-08 AT AT0093379A patent/AT374183B/en active
- 1979-02-12 GR GR58339A patent/GR66565B/el unknown
- 1979-02-13 DD DD79211007A patent/DD141829A5/en unknown
- 1979-02-14 RO RO7996613A patent/RO76683A/en unknown
- 1979-02-14 RO RO79103556A patent/RO82013A/en unknown
- 1979-02-15 IL IL56677A patent/IL56677A/en unknown
- 1979-02-15 FI FI790507A patent/FI69064C/en not_active IP Right Cessation
- 1979-02-15 YU YU366/79A patent/YU41146B/en unknown
- 1979-02-16 HU HU79TO1094A patent/HU177522B/en unknown
- 1979-02-16 PT PT69244A patent/PT69244A/en unknown
- 1979-02-16 PL PL1979222632A patent/PL119177B1/en unknown
- 1979-02-16 NZ NZ189685A patent/NZ189685A/en unknown
- 1979-02-16 PL PL1979213471A patent/PL117771B1/en unknown
- 1979-02-16 NO NO790521A patent/NO152839C/en unknown
- 1979-02-16 IE IE313/79A patent/IE48179B1/en unknown
- 1979-02-16 AU AU44329/79A patent/AU523147B2/en not_active Ceased
- 1979-02-16 JP JP1716179A patent/JPS54132581A/en active Granted
- 1979-02-16 DK DK069679A patent/DK157017C/en not_active IP Right Cessation
- 1979-02-16 PL PL1979222631A patent/PL119423B1/en unknown
- 1979-02-19 CA CA000321738A patent/CA1116600A/en not_active Expired
- 1979-02-19 CS CS791091A patent/CS227005B2/en unknown
- 1979-10-01 ES ES484633A patent/ES484633A1/en not_active Expired
- 1979-10-01 ES ES484634A patent/ES484634A1/en not_active Expired
- 1979-10-24 SU SU792835387A patent/SU852170A3/en active
-
1980
- 1980-08-01 PH PH24380A patent/PH16698A/en unknown
-
1985
- 1985-07-04 HK HK504/85A patent/HK50485A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO151321C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES | |
NO151463C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CHINAZOLINE DERIVATIVES | |
NO152215C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 4,5-DIARYL-2-NITROIMIDAZOLES | |
NO152899C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE GLYCEROL DERIVATIVES. | |
NO158099C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES. | |
NO153177C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE TETRAZOLYLALCOXY CARBOSTYRIC DERIVATIVES. | |
NO149102C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TRANS-4-PHENYL-1,2,3,4-TETRAHYDRO-1-Naphthalene-amine Derivatives | |
NO147243C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PHTALAND DERIVATIVES | |
NO156864C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PIPERIN DERIVATIVES. | |
NO151411C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1-ARYLOXY-2-HYDROXY-3-ALKYLENAMINOPROPANE DERIVATIVES | |
NO153569C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BRAND CAPACETYL-PROLIN DERIVATIVES. | |
NO152129C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OMEGA-CYAN-1, OMEGA-DIFENYL-AZAALKANDER DERIVATIVES | |
NO156787C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE QUINOLO DERIVATIVES. | |
NO152414C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVITY 2,6-DIALCOXYBENZAMIDES | |
NO151239C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-PHENYLIMINOIMIDAZOLIDINES | |
NO160079C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CEFEM DERIVATIVES. | |
NO154054C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE HYDROXYPYRIMIDINE DERIVATIVES. | |
NO158739C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-PIPERAZINOPYRIMIDINE DERIVATIVES. | |
NO151285C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE DI-O-N-ALKYL-GLYCEROLD DERIVATIVES | |
NO151660C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLD DERIVATIVES. | |
NO160512C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES. | |
NO154052C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE QUINOLON DERIVATIVES. | |
NO146863C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALKYLTIOPHENOXYLKYLAMINES | |
NO152839C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES. | |
NO154088C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TETRAHYDROKINOLINES. |